chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Nasal congestion, Nausea, Pain
Clinical narrative: Nausea, headache, Weakness, Aches and Pains, minor throat irritation, & minor nasal congestion
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: Nausea, headache, Weakness, Aches and Pains, minor throat irritation, & minor nasal congestion
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Chest pain, Chills, Computerised tomogram thorax, Dyspnoea
Clinical narrative: Per Client received Pfizer COVID 19 vaccine second dose on 3/28/2021, at 1:00pm in left arm. Client C/O symptoms starting on 3/28/2021 around 9:00pm, fever and chills. ON 3/30/2021 started having difficulty with breathing, chest pain, racing pulse an increased blood pressure through 3/31/2021, so the Client went into the ER on 3/31/2021. In ER Client had a CT of chest performed and is currently wearing a internal heart monitor for other medical concerns present prior to vaccine. Per Client some of symptoms have subsided and Client will plan to follow up with PCP. PHN suggested that Client continue to monitor symptoms, follow up with PCP and go back to ER if needed and call 911 for medical emergency.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Pyrexia
Clinical narrative: Per Client received Pfizer COVID 19 vaccine second dose on 3/28/2021, at 1:00pm in left arm. Client C/O symptoms starting on 3/28/2021 around 9:00pm, fever and chills. ON 3/30/2021 started having difficulty with breathing, chest pain, racing pulse an increased blood pressure through 3/31/2021, so the Client went into the ER on 3/31/2021. In ER Client had a CT of chest performed and is currently wearing a internal heart monitor for other medical concerns present prior to vaccine. Per Client some of symptoms have subsided and Client will plan to follow up with PCP. PHN suggested that Client continue to monitor symptoms, follow up with PCP and go back to ER if needed and call 911 for medical emergency.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody, Antinuclear antibody increased, Antinuclear antibody negative, Biopsy kidney, Blood creatine phosphokinase normal
Clinical narrative: 71- year old woman with past medical significant for hypertension on 10 mg of Lisinopril daily for many years. She had her first dose of Pfizer vaccine two weeks prior to admission (3/11/21). After her vaccination, patient felt unwell and dizzy in the mornings. She felt persistent fatigue and had a decreased appetite. The week prior to admission she noticed a decrease in her urine output. She denied NSAID use. Her primary care physician ordered blood week and her Cr was found to be 16.54 and BUN of 163, phosphate of 17.5. Her last known Cr prior to her admission was 18 months prior and was 1.17. She was asked to present to the emergency room. Renal ultrasound showed no hydronephrosis or stones. Urinalysis showed 1+ protein, spec grav of 1.023 with a urine protein/creatinine ratio of 0.09. Urine sediment was unremarkable. Her temperature was 95.6 and her BP was as low as 75/46 and she was put on a low dose of levo. CRP was 202.3. COVID was negative. CK wnl.  ANA + to 1:160 (dsDNA, Smith, RNP, SS-A, SS-B all negative). Blood smear was negative. Cultures were all negative. Echo showed an EF of 68% with trivial pericardial effusion. Patient was oliguric, and then initiated on hemodialysis. Renal biopsy was performed.   The biopsy consists of one fragment which is stained with H&E, PAS, Trichrome, Jones Silver, and HPS stains. Review of all stains reveals 12 glomeruli, one of which is globally sclerotic. The architecture of the kidney is well-preserved. There is  interstitial fibrosis with proportional atrophy involving 10% of the biopsy tissue. There is a focal interstitial infiltrate consisting of lymphocytes involving <5% of the interstitium. The tubules show diffuse acute tubular injury.  Calcium oxalate  crystals are present in seven tubular profiles. The glomeruli show expansion of Bowman's capsule. The mesangium shows normal cellularity. The vessels show no abnormalities.   IMMUNOFLUORESCENCE MICROSCOPY:   Frozen sections are stained for IgA, IgG, IgM, C3, C1q, kappa, lambda, and fibrinogen. All immunofluorescence stains are negative.   ELECTRON MICROSCOPY:   Specimens are prepared for electron microscopy and semi-thin sections stained with toluidine blue are reviewed prior to thin sectioning for ultrastructural examination. Electron microscopy demonstrates patent capillary loops. The glomerular architecture  demonstrates segmental corrugation of basement membranes with increase in lamina rara interna.  No subepithelial deposits and no intramembranous deposits are identified. The tubules show dilated mitochondria and injury. There is segmental effacement of  foot processes. There are no subendothelial deposits. Mesangial electron dense deposits are not identified.   Patient received three dialysis treatments and Creatinine began to improved down to 1.46 within 8 days.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatinine increased, Blood fibrinogen, Blood immunoglobulin G normal, Blood phosphorus increased, Blood smear test normal
Clinical narrative: 71- year old woman with past medical significant for hypertension on 10 mg of Lisinopril daily for many years. She had her first dose of Pfizer vaccine two weeks prior to admission (3/11/21). After her vaccination, patient felt unwell and dizzy in the mornings. She felt persistent fatigue and had a decreased appetite. The week prior to admission she noticed a decrease in her urine output. She denied NSAID use. Her primary care physician ordered blood week and her Cr was found to be 16.54 and BUN of 163, phosphate of 17.5. Her last known Cr prior to her admission was 18 months prior and was 1.17. She was asked to present to the emergency room. Renal ultrasound showed no hydronephrosis or stones. Urinalysis showed 1+ protein, spec grav of 1.023 with a urine protein/creatinine ratio of 0.09. Urine sediment was unremarkable. Her temperature was 95.6 and her BP was as low as 75/46 and she was put on a low dose of levo. CRP was 202.3. COVID was negative. CK wnl.  ANA + to 1:160 (dsDNA, Smith, RNP, SS-A, SS-B all negative). Blood smear was negative. Cultures were all negative. Echo showed an EF of 68% with trivial pericardial effusion. Patient was oliguric, and then initiated on hemodialysis. Renal biopsy was performed.   The biopsy consists of one fragment which is stained with H&E, PAS, Trichrome, Jones Silver, and HPS stains. Review of all stains reveals 12 glomeruli, one of which is globally sclerotic. The architecture of the kidney is well-preserved. There is  interstitial fibrosis with proportional atrophy involving 10% of the biopsy tissue. There is a focal interstitial infiltrate consisting of lymphocytes involving <5% of the interstitium. The tubules show diffuse acute tubular injury.  Calcium oxalate  crystals are present in seven tubular profiles. The glomeruli show expansion of Bowman's capsule. The mesangium shows normal cellularity. The vessels show no abnormalities.   IMMUNOFLUORESCENCE MICROSCOPY:   Frozen sections are stained for IgA, IgG, IgM, C3, C1q, kappa, lambda, and fibrinogen. All immunofluorescence stains are negative.   ELECTRON MICROSCOPY:   Specimens are prepared for electron microscopy and semi-thin sections stained with toluidine blue are reviewed prior to thin sectioning for ultrastructural examination. Electron microscopy demonstrates patent capillary loops. The glomerular architecture  demonstrates segmental corrugation of basement membranes with increase in lamina rara interna.  No subepithelial deposits and no intramembranous deposits are identified. The tubules show dilated mitochondria and injury. There is segmental effacement of  foot processes. There are no subendothelial deposits. Mesangial electron dense deposits are not identified.   Patient received three dialysis treatments and Creatinine began to improved down to 1.46 within 8 days.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urea increased, C-reactive protein increased, Chronic allograft nephropathy, Complement factor C3, Crystal urine present
Clinical narrative: 71- year old woman with past medical significant for hypertension on 10 mg of Lisinopril daily for many years. She had her first dose of Pfizer vaccine two weeks prior to admission (3/11/21). After her vaccination, patient felt unwell and dizzy in the mornings. She felt persistent fatigue and had a decreased appetite. The week prior to admission she noticed a decrease in her urine output. She denied NSAID use. Her primary care physician ordered blood week and her Cr was found to be 16.54 and BUN of 163, phosphate of 17.5. Her last known Cr prior to her admission was 18 months prior and was 1.17. She was asked to present to the emergency room. Renal ultrasound showed no hydronephrosis or stones. Urinalysis showed 1+ protein, spec grav of 1.023 with a urine protein/creatinine ratio of 0.09. Urine sediment was unremarkable. Her temperature was 95.6 and her BP was as low as 75/46 and she was put on a low dose of levo. CRP was 202.3. COVID was negative. CK wnl.  ANA + to 1:160 (dsDNA, Smith, RNP, SS-A, SS-B all negative). Blood smear was negative. Cultures were all negative. Echo showed an EF of 68% with trivial pericardial effusion. Patient was oliguric, and then initiated on hemodialysis. Renal biopsy was performed.   The biopsy consists of one fragment which is stained with H&E, PAS, Trichrome, Jones Silver, and HPS stains. Review of all stains reveals 12 glomeruli, one of which is globally sclerotic. The architecture of the kidney is well-preserved. There is  interstitial fibrosis with proportional atrophy involving 10% of the biopsy tissue. There is a focal interstitial infiltrate consisting of lymphocytes involving <5% of the interstitium. The tubules show diffuse acute tubular injury.  Calcium oxalate  crystals are present in seven tubular profiles. The glomeruli show expansion of Bowman's capsule. The mesangium shows normal cellularity. The vessels show no abnormalities.   IMMUNOFLUORESCENCE MICROSCOPY:   Frozen sections are stained for IgA, IgG, IgM, C3, C1q, kappa, lambda, and fibrinogen. All immunofluorescence stains are negative.   ELECTRON MICROSCOPY:   Specimens are prepared for electron microscopy and semi-thin sections stained with toluidine blue are reviewed prior to thin sectioning for ultrastructural examination. Electron microscopy demonstrates patent capillary loops. The glomerular architecture  demonstrates segmental corrugation of basement membranes with increase in lamina rara interna.  No subepithelial deposits and no intramembranous deposits are identified. The tubules show dilated mitochondria and injury. There is segmental effacement of  foot processes. There are no subendothelial deposits. Mesangial electron dense deposits are not identified.   Patient received three dialysis treatments and Creatinine began to improved down to 1.46 within 8 days.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Culture negative, Culture urine negative, Decreased appetite, Dizziness, Double stranded DNA antibody
Clinical narrative: 71- year old woman with past medical significant for hypertension on 10 mg of Lisinopril daily for many years. She had her first dose of Pfizer vaccine two weeks prior to admission (3/11/21). After her vaccination, patient felt unwell and dizzy in the mornings. She felt persistent fatigue and had a decreased appetite. The week prior to admission she noticed a decrease in her urine output. She denied NSAID use. Her primary care physician ordered blood week and her Cr was found to be 16.54 and BUN of 163, phosphate of 17.5. Her last known Cr prior to her admission was 18 months prior and was 1.17. She was asked to present to the emergency room. Renal ultrasound showed no hydronephrosis or stones. Urinalysis showed 1+ protein, spec grav of 1.023 with a urine protein/creatinine ratio of 0.09. Urine sediment was unremarkable. Her temperature was 95.6 and her BP was as low as 75/46 and she was put on a low dose of levo. CRP was 202.3. COVID was negative. CK wnl.  ANA + to 1:160 (dsDNA, Smith, RNP, SS-A, SS-B all negative). Blood smear was negative. Cultures were all negative. Echo showed an EF of 68% with trivial pericardial effusion. Patient was oliguric, and then initiated on hemodialysis. Renal biopsy was performed.   The biopsy consists of one fragment which is stained with H&E, PAS, Trichrome, Jones Silver, and HPS stains. Review of all stains reveals 12 glomeruli, one of which is globally sclerotic. The architecture of the kidney is well-preserved. There is  interstitial fibrosis with proportional atrophy involving 10% of the biopsy tissue. There is a focal interstitial infiltrate consisting of lymphocytes involving <5% of the interstitium. The tubules show diffuse acute tubular injury.  Calcium oxalate  crystals are present in seven tubular profiles. The glomeruli show expansion of Bowman's capsule. The mesangium shows normal cellularity. The vessels show no abnormalities.   IMMUNOFLUORESCENCE MICROSCOPY:   Frozen sections are stained for IgA, IgG, IgM, C3, C1q, kappa, lambda, and fibrinogen. All immunofluorescence stains are negative.   ELECTRON MICROSCOPY:   Specimens are prepared for electron microscopy and semi-thin sections stained with toluidine blue are reviewed prior to thin sectioning for ultrastructural examination. Electron microscopy demonstrates patent capillary loops. The glomerular architecture  demonstrates segmental corrugation of basement membranes with increase in lamina rara interna.  No subepithelial deposits and no intramembranous deposits are identified. The tubules show dilated mitochondria and injury. There is segmental effacement of  foot processes. There are no subendothelial deposits. Mesangial electron dense deposits are not identified.   Patient received three dialysis treatments and Creatinine began to improved down to 1.46 within 8 days.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Ejection fraction normal, Fatigue, Haemodialysis, Hypotension, Immune complex assay
Clinical narrative: 71- year old woman with past medical significant for hypertension on 10 mg of Lisinopril daily for many years. She had her first dose of Pfizer vaccine two weeks prior to admission (3/11/21). After her vaccination, patient felt unwell and dizzy in the mornings. She felt persistent fatigue and had a decreased appetite. The week prior to admission she noticed a decrease in her urine output. She denied NSAID use. Her primary care physician ordered blood week and her Cr was found to be 16.54 and BUN of 163, phosphate of 17.5. Her last known Cr prior to her admission was 18 months prior and was 1.17. She was asked to present to the emergency room. Renal ultrasound showed no hydronephrosis or stones. Urinalysis showed 1+ protein, spec grav of 1.023 with a urine protein/creatinine ratio of 0.09. Urine sediment was unremarkable. Her temperature was 95.6 and her BP was as low as 75/46 and she was put on a low dose of levo. CRP was 202.3. COVID was negative. CK wnl.  ANA + to 1:160 (dsDNA, Smith, RNP, SS-A, SS-B all negative). Blood smear was negative. Cultures were all negative. Echo showed an EF of 68% with trivial pericardial effusion. Patient was oliguric, and then initiated on hemodialysis. Renal biopsy was performed.   The biopsy consists of one fragment which is stained with H&E, PAS, Trichrome, Jones Silver, and HPS stains. Review of all stains reveals 12 glomeruli, one of which is globally sclerotic. The architecture of the kidney is well-preserved. There is  interstitial fibrosis with proportional atrophy involving 10% of the biopsy tissue. There is a focal interstitial infiltrate consisting of lymphocytes involving <5% of the interstitium. The tubules show diffuse acute tubular injury.  Calcium oxalate  crystals are present in seven tubular profiles. The glomeruli show expansion of Bowman's capsule. The mesangium shows normal cellularity. The vessels show no abnormalities.   IMMUNOFLUORESCENCE MICROSCOPY:   Frozen sections are stained for IgA, IgG, IgM, C3, C1q, kappa, lambda, and fibrinogen. All immunofluorescence stains are negative.   ELECTRON MICROSCOPY:   Specimens are prepared for electron microscopy and semi-thin sections stained with toluidine blue are reviewed prior to thin sectioning for ultrastructural examination. Electron microscopy demonstrates patent capillary loops. The glomerular architecture  demonstrates segmental corrugation of basement membranes with increase in lamina rara interna.  No subepithelial deposits and no intramembranous deposits are identified. The tubules show dilated mitochondria and injury. There is segmental effacement of  foot processes. There are no subendothelial deposits. Mesangial electron dense deposits are not identified.   Patient received three dialysis treatments and Creatinine began to improved down to 1.46 within 8 days.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Immunology test, Light chain analysis, Lymphocytic infiltration, Malaise, Microscopy
Clinical narrative: 71- year old woman with past medical significant for hypertension on 10 mg of Lisinopril daily for many years. She had her first dose of Pfizer vaccine two weeks prior to admission (3/11/21). After her vaccination, patient felt unwell and dizzy in the mornings. She felt persistent fatigue and had a decreased appetite. The week prior to admission she noticed a decrease in her urine output. She denied NSAID use. Her primary care physician ordered blood week and her Cr was found to be 16.54 and BUN of 163, phosphate of 17.5. Her last known Cr prior to her admission was 18 months prior and was 1.17. She was asked to present to the emergency room. Renal ultrasound showed no hydronephrosis or stones. Urinalysis showed 1+ protein, spec grav of 1.023 with a urine protein/creatinine ratio of 0.09. Urine sediment was unremarkable. Her temperature was 95.6 and her BP was as low as 75/46 and she was put on a low dose of levo. CRP was 202.3. COVID was negative. CK wnl.  ANA + to 1:160 (dsDNA, Smith, RNP, SS-A, SS-B all negative). Blood smear was negative. Cultures were all negative. Echo showed an EF of 68% with trivial pericardial effusion. Patient was oliguric, and then initiated on hemodialysis. Renal biopsy was performed.   The biopsy consists of one fragment which is stained with H&E, PAS, Trichrome, Jones Silver, and HPS stains. Review of all stains reveals 12 glomeruli, one of which is globally sclerotic. The architecture of the kidney is well-preserved. There is  interstitial fibrosis with proportional atrophy involving 10% of the biopsy tissue. There is a focal interstitial infiltrate consisting of lymphocytes involving <5% of the interstitium. The tubules show diffuse acute tubular injury.  Calcium oxalate  crystals are present in seven tubular profiles. The glomeruli show expansion of Bowman's capsule. The mesangium shows normal cellularity. The vessels show no abnormalities.   IMMUNOFLUORESCENCE MICROSCOPY:   Frozen sections are stained for IgA, IgG, IgM, C3, C1q, kappa, lambda, and fibrinogen. All immunofluorescence stains are negative.   ELECTRON MICROSCOPY:   Specimens are prepared for electron microscopy and semi-thin sections stained with toluidine blue are reviewed prior to thin sectioning for ultrastructural examination. Electron microscopy demonstrates patent capillary loops. The glomerular architecture  demonstrates segmental corrugation of basement membranes with increase in lamina rara interna.  No subepithelial deposits and no intramembranous deposits are identified. The tubules show dilated mitochondria and injury. There is segmental effacement of  foot processes. There are no subendothelial deposits. Mesangial electron dense deposits are not identified.   Patient received three dialysis treatments and Creatinine began to improved down to 1.46 within 8 days.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pericardial effusion, Protein urine absent, Renal tubular injury, SARS-CoV-2 test negative, Specific gravity urine normal
Clinical narrative: 71- year old woman with past medical significant for hypertension on 10 mg of Lisinopril daily for many years. She had her first dose of Pfizer vaccine two weeks prior to admission (3/11/21). After her vaccination, patient felt unwell and dizzy in the mornings. She felt persistent fatigue and had a decreased appetite. The week prior to admission she noticed a decrease in her urine output. She denied NSAID use. Her primary care physician ordered blood week and her Cr was found to be 16.54 and BUN of 163, phosphate of 17.5. Her last known Cr prior to her admission was 18 months prior and was 1.17. She was asked to present to the emergency room. Renal ultrasound showed no hydronephrosis or stones. Urinalysis showed 1+ protein, spec grav of 1.023 with a urine protein/creatinine ratio of 0.09. Urine sediment was unremarkable. Her temperature was 95.6 and her BP was as low as 75/46 and she was put on a low dose of levo. CRP was 202.3. COVID was negative. CK wnl.  ANA + to 1:160 (dsDNA, Smith, RNP, SS-A, SS-B all negative). Blood smear was negative. Cultures were all negative. Echo showed an EF of 68% with trivial pericardial effusion. Patient was oliguric, and then initiated on hemodialysis. Renal biopsy was performed.   The biopsy consists of one fragment which is stained with H&E, PAS, Trichrome, Jones Silver, and HPS stains. Review of all stains reveals 12 glomeruli, one of which is globally sclerotic. The architecture of the kidney is well-preserved. There is  interstitial fibrosis with proportional atrophy involving 10% of the biopsy tissue. There is a focal interstitial infiltrate consisting of lymphocytes involving <5% of the interstitium. The tubules show diffuse acute tubular injury.  Calcium oxalate  crystals are present in seven tubular profiles. The glomeruli show expansion of Bowman's capsule. The mesangium shows normal cellularity. The vessels show no abnormalities.   IMMUNOFLUORESCENCE MICROSCOPY:   Frozen sections are stained for IgA, IgG, IgM, C3, C1q, kappa, lambda, and fibrinogen. All immunofluorescence stains are negative.   ELECTRON MICROSCOPY:   Specimens are prepared for electron microscopy and semi-thin sections stained with toluidine blue are reviewed prior to thin sectioning for ultrastructural examination. Electron microscopy demonstrates patent capillary loops. The glomerular architecture  demonstrates segmental corrugation of basement membranes with increase in lamina rara interna.  No subepithelial deposits and no intramembranous deposits are identified. The tubules show dilated mitochondria and injury. There is segmental effacement of  foot processes. There are no subendothelial deposits. Mesangial electron dense deposits are not identified.   Patient received three dialysis treatments and Creatinine began to improved down to 1.46 within 8 days.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound kidney normal, Urinary sediment, Urine output decreased, Urine protein/creatinine ratio normal
Clinical narrative: 71- year old woman with past medical significant for hypertension on 10 mg of Lisinopril daily for many years. She had her first dose of Pfizer vaccine two weeks prior to admission (3/11/21). After her vaccination, patient felt unwell and dizzy in the mornings. She felt persistent fatigue and had a decreased appetite. The week prior to admission she noticed a decrease in her urine output. She denied NSAID use. Her primary care physician ordered blood week and her Cr was found to be 16.54 and BUN of 163, phosphate of 17.5. Her last known Cr prior to her admission was 18 months prior and was 1.17. She was asked to present to the emergency room. Renal ultrasound showed no hydronephrosis or stones. Urinalysis showed 1+ protein, spec grav of 1.023 with a urine protein/creatinine ratio of 0.09. Urine sediment was unremarkable. Her temperature was 95.6 and her BP was as low as 75/46 and she was put on a low dose of levo. CRP was 202.3. COVID was negative. CK wnl.  ANA + to 1:160 (dsDNA, Smith, RNP, SS-A, SS-B all negative). Blood smear was negative. Cultures were all negative. Echo showed an EF of 68% with trivial pericardial effusion. Patient was oliguric, and then initiated on hemodialysis. Renal biopsy was performed.   The biopsy consists of one fragment which is stained with H&E, PAS, Trichrome, Jones Silver, and HPS stains. Review of all stains reveals 12 glomeruli, one of which is globally sclerotic. The architecture of the kidney is well-preserved. There is  interstitial fibrosis with proportional atrophy involving 10% of the biopsy tissue. There is a focal interstitial infiltrate consisting of lymphocytes involving <5% of the interstitium. The tubules show diffuse acute tubular injury.  Calcium oxalate  crystals are present in seven tubular profiles. The glomeruli show expansion of Bowman's capsule. The mesangium shows normal cellularity. The vessels show no abnormalities.   IMMUNOFLUORESCENCE MICROSCOPY:   Frozen sections are stained for IgA, IgG, IgM, C3, C1q, kappa, lambda, and fibrinogen. All immunofluorescence stains are negative.   ELECTRON MICROSCOPY:   Specimens are prepared for electron microscopy and semi-thin sections stained with toluidine blue are reviewed prior to thin sectioning for ultrastructural examination. Electron microscopy demonstrates patent capillary loops. The glomerular architecture  demonstrates segmental corrugation of basement membranes with increase in lamina rara interna.  No subepithelial deposits and no intramembranous deposits are identified. The tubules show dilated mitochondria and injury. There is segmental effacement of  foot processes. There are no subendothelial deposits. Mesangial electron dense deposits are not identified.   Patient received three dialysis treatments and Creatinine began to improved down to 1.46 within 8 days.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Electrocardiogram, Syncope
Clinical narrative: Syncope, lightheadedness. Observation had him walk and he fainted while walking. Ate Crepes for breakfast, lunch he had chips and a small cup of water.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus began a few days after I received the vaccination.  It has not gone away.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Computerised tomogram, Electrocardiogram, Fatigue, Hypotension
Clinical narrative: Felt fatigue when I went out first few weeks after vaccination...3rd week fatigue was extreme and overwhelming... recommended I be tested that evening for cova d...at facility...determined my blood pressure extremely low... when could not elevate blood pressure sent me to hospital...emergency room doctor said he believed my exact symptoms were traced to the moderna cova d vaccine
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Urine analysis
Clinical narrative: Felt fatigue when I went out first few weeks after vaccination...3rd week fatigue was extreme and overwhelming... recommended I be tested that evening for cova d...at facility...determined my blood pressure extremely low... when could not elevate blood pressure sent me to hospital...emergency room doctor said he believed my exact symptoms were traced to the moderna cova d vaccine
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Short dizzy spells, sometimes pretty strong. The first one (and the strongest) was on April 14, nine days after vaccination. It lasted between 30 and 60 seconds. Today, eleven days after vaccination, I'm experiencing them more often but not as strong.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles, COVID Toes
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Fear, Pallor, Paraesthesia, Syncope
Clinical narrative: pale, faint, fingers tingled, scared
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Glossodynia, Injection site pain, Pyrexia, Tongue blistering
Clinical narrative: Within 24 hrs developed clusters of blisters on posterior area of tongue. Blisters surrounded by layer of white film.  Moderate pain in location of blisters, also accompanied by fever, fatigue, pain at injection site. Tongue blisters & white film reduced significantly by 24 hrs after presentation. Improvement continued for all symptoms. 72 hrs after presentation, blisters & white film no longer visible. No fever, fatigue, no pain at injection site.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Client arrived to Public COVID-19 vaccination clinic as a walk-up appointment. Client requested his second dose of the Moderna vaccine. The vaccine was administered. It was noted post-vaccination that the client received his second dose 1 week early (3 weeks in between doses). The client was notified. It was noted on the CDC website that no further doses are indicated at this time.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Condition aggravated, Fatigue, Hypoaesthesia
Clinical narrative: Same day of vacc. - pain in left arm, difficultyifting left arm, numbness in face and right arm, nausea, fatigue, weakness in limbs, joint pain in right hip, shoulders, legs, arms.  Day after vacc. - migraine, right hip joint pain, weakness in right leg, numbness in face and right arm, nausea, left arm pain, difficulty lifting arm, fatigue, general weakness.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Mobility decreased, Muscular weakness, Nausea, Pain in extremity
Clinical narrative: Same day of vacc. - pain in left arm, difficultyifting left arm, numbness in face and right arm, nausea, fatigue, weakness in limbs, joint pain in right hip, shoulders, legs, arms.  Day after vacc. - migraine, right hip joint pain, weakness in right leg, numbness in face and right arm, nausea, left arm pain, difficulty lifting arm, fatigue, general weakness.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot
Clinical narrative: Patient was feeling a little ligthheaded and warm. She said she has had a history of anxiety around needles.  Blood pressure was taken 2 times with blood pressure cuff pharmacy staff had on hand, readings were 153/130, 165/137. Patient says she "normally runs around normal, 120/80." Patient was given water, patient remained in her seat for about 15 minutes, blood pressure taken again 140/100. Patient remained in waiting area another 15 minutes, patient said she felt fine, and had groceries to get in store. She said that she would contact us if feeling anything else while getting groceries, and then left observation area.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Back pain, Breast pain, Fatigue
Clinical narrative: 24hrs after the second vaccine I had the usual reactions: fatigue, nausea, body aches. On the 2nd day I woke up without any discomfort and was fine for 6-7 days.  SEVEN DAYS AFTER THE 2ND VACCINE: Jabbing, throbbing pain, itching and "running ants" located in: hands, (knuckles, wrists, palms, both sides), forearms, armpits and under breasts, upper back between shoulder blades, upper ribs, thighs, behind knees, and bottoms of the feet. Ongoing, all over, both sides of the body going on now for 48hrs.  I do not have any history of fibromyalgia.   Constant urination. Difficult to sleep. Fatigue.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal chest pain, Nausea, Pain, Pain in extremity, Pollakiuria
Clinical narrative: 24hrs after the second vaccine I had the usual reactions: fatigue, nausea, body aches. On the 2nd day I woke up without any discomfort and was fine for 6-7 days.  SEVEN DAYS AFTER THE 2ND VACCINE: Jabbing, throbbing pain, itching and "running ants" located in: hands, (knuckles, wrists, palms, both sides), forearms, armpits and under breasts, upper back between shoulder blades, upper ribs, thighs, behind knees, and bottoms of the feet. Ongoing, all over, both sides of the body going on now for 48hrs.  I do not have any history of fibromyalgia.   Constant urination. Difficult to sleep. Fatigue.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Sleep disorder
Clinical narrative: 24hrs after the second vaccine I had the usual reactions: fatigue, nausea, body aches. On the 2nd day I woke up without any discomfort and was fine for 6-7 days.  SEVEN DAYS AFTER THE 2ND VACCINE: Jabbing, throbbing pain, itching and "running ants" located in: hands, (knuckles, wrists, palms, both sides), forearms, armpits and under breasts, upper back between shoulder blades, upper ribs, thighs, behind knees, and bottoms of the feet. Ongoing, all over, both sides of the body going on now for 48hrs.  I do not have any history of fibromyalgia.   Constant urination. Difficult to sleep. Fatigue.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Chills, Headache, Nausea
Clinical narrative: Fainting, headache, stomach ache, nausea, weakness, chills
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: Fainting, headache, stomach ache, nausea, weakness, chills
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Rash, Rash erythematous
Clinical narrative: Patient received a corticosteroid injection into her knee approximately nine days after her second dose of the Moderna Covid vaccine.  Patient subsequently developed a red rash on her face beginning 9 days after dose two of Moderna and lasting at least five days from onset.  On day 10, she also experience a swollen lymph node under her chin on the left side.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash papular, Rash pruritic
Clinical narrative: I have had an incredibly itchy, raised rash all over my legs, arms and torso since the day after the administration of the 2nd dose. It is seemingly getting worse, not better as of today (9 days post vaccine).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chillblains
Clinical narrative: Chilblains started in my right hand?s pointer finger off and on for 4-5 days. Would last 10 mins tops 4-5xs a day but today it is all of my fingers in that hand.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Mobility decreased, Movement disorder, Myalgia, Pain
Clinical narrative: Extreme shoulder pain immediately upon receiving shot.  Arm became sore and unable to move or lift arm.  I have extreme muscle pain around the shoulder. Mobility of the are is very limited and constantly aches. It is hard to sleep. I am about 7 weeks out from receiving the shot and my arm is still injured.  I was prescribed Meloxicam 15MG after visiting doctor on March 11, 2021. I was told I have shoulder tendonitis.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Tendonitis
Clinical narrative: Extreme shoulder pain immediately upon receiving shot.  Arm became sore and unable to move or lift arm.  I have extreme muscle pain around the shoulder. Mobility of the are is very limited and constantly aches. It is hard to sleep. I am about 7 weeks out from receiving the shot and my arm is still injured.  I was prescribed Meloxicam 15MG after visiting doctor on March 11, 2021. I was told I have shoulder tendonitis.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Neck pain, Pyrexia
Clinical narrative: Soreness in neck, sore at injection site, fatigue, low grade fever (99.2)
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling cold, Feeling hot, Migraine, Peripheral coldness
Clinical narrative: 1.  Migraine level headache, 2.  Body hot and cold before finally settling on cold, 3.  Left hand was cold as ice, 4.  No fever, 5.  Took two acetaminophen, then slept for 4 hours. 6.  Felt better after 4 hours.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Paraesthesia
Clinical narrative: Patient reports symptoms at 1514 of parensthesias to posterior neck and right arm followed by dizziness and shortness of breath. Denies tightness to throat or dysphagia. VS bp 125/80 pulse 83 oxygen 99%. At 1520 patient reports complete resolution of symptoms including shortness of breath. Oxygenation continues 99%  patient accompanied by significant other home.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Haemorrhage
Clinical narrative: Patient reported no adverse reactions after and the days after receiving JJ Covid vaccine.  Fast forward, as he was talking to me on 4/16/21, he revealed that he did have one event that occurred the morning after he received the vaccine which was 3/9/21.  He said that he had reservations reporting it to me at the time.  He did contact his primary doctor about it and had a check up.  On the morning for 4/9/21, he walked into his shower then looked down at his feet, he notice blood on the floor of the shower.  At this time, the water was not on yet.  He described the blood as pink.  He said he thought he lost about 1-2 ounces of blood.  He only had one incident and none other.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Differential white blood cell count, Dysphonia, Full blood count, Metabolic function test
Clinical narrative: Throat swelling, hoarse voice, chest tightness and red rash. Allergic reaction.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Rash erythematous
Clinical narrative: Throat swelling, hoarse voice, chest tightness and red rash. Allergic reaction.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscle spasms, Pyrexia
Clinical narrative: The night of 4/1, 12 hours after vaccine, I woke up with a fever of 103 and was having muscle spasms in my arms and legs, and felt like my whole body was vibrating. My fingers were frozen, I could not feel them.   2 weeks later (last night) 4/15/21, I woke up feeling the vibrating sensation again. It feels like my whole body, muscles, everything are vibrating. I had muscle spasms in my arms and legs.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heavy menstrual bleeding, Migraine, Swelling
Clinical narrative: 1) EXTENDED MENSTRUATION 2) MIGRAINES 3) SWELLING OF EXTREMITIES 4) DIFFICULTY BREATHING
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Nasal congestion, Rhinorrhoea, SARS-CoV-2 test negative
Clinical narrative: I started having extremely bad headaches on 4/14/2021 that are continuing as of 4/16/2021. I also have congestion and a runny nose that I did not have previously.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I started having extremely bad headaches on 4/14/2021 that are continuing as of 4/16/2021. I also have congestion and a runny nose that I did not have previously.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Contusion, Renal pain, Solar lentigo
Clinical narrative: BACK PAIN IN KIDNEY AREA, BRUISING THAT LOOKS LIKE LIVER SPOTS.  REPORTS THAT THIS BEGAN RIGHT AFTER VACCINE.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling in feet; BP 110-152; 76-82; HR 81; RR 16
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Injection site discomfort, Injection site erythema, Injection site pain, Injection site swelling, Pain in extremity
Clinical narrative: Initially with localized reaction with redness, swelling, tenderness, low grade fever.  She was treated with a course of oral antibiotics for possible cellulitis without improvement.  She continued to have redness around the injection site and discomfort.  She was then treated with a topical steroid without benefit.  She then took a 5 day course of oral steroids after which the redness resolved.  She continues to have thigh pain now 2 months later.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Pyrexia
Clinical narrative: Initially with localized reaction with redness, swelling, tenderness, low grade fever.  She was treated with a course of oral antibiotics for possible cellulitis without improvement.  She continued to have redness around the injection site and discomfort.  She was then treated with a topical steroid without benefit.  She then took a 5 day course of oral steroids after which the redness resolved.  She continues to have thigh pain now 2 months later.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous
Clinical narrative: Suffered a miscarriage. My due date was 10/1/21
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fall, Foot deformity, Head injury, Loss of consciousness
Clinical narrative: This patient had received vaccination and was scheduling next appt in observation area. Medical alert called overhead. RN responded to alert. Pt conscious, but per RN, in observation area, she stated he had a loss of consciousness and although she tried to break his fall, he did hit his head on the wall. Pt was sitting in chair, vitals attempted to be assessed, no reading, but patient alert. Before vitals were repeated,16:18 pt eyes drifted left and closing, another loss of consciousness, followed by convulsions and gasping sounds from the throat. Pt convulsed and left leg /foot turned inward torsion. Pt was removed from chair by 3 RN's to floor safely. approximately 15-30seconds of convulsion. pt regained consciousness AOX4. Pt remained laying, head propped on cushion. vitals taken 16:24 BP 108/69 86bpm, 100%O2Sat. MD assessed and pt stable. MD provided recommendation for pt to be evaluated at ED for further evaluation due to the convulsions. Pt accompanied by friend, friend agreed to drive pt to ED. Blood Glucose 90, which was taken at 1630.  Wheelchair was provided for patient, RN rolled pt out to car and friend designated driver.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: This patient had received vaccination and was scheduling next appt in observation area. Medical alert called overhead. RN responded to alert. Pt conscious, but per RN, in observation area, she stated he had a loss of consciousness and although she tried to break his fall, he did hit his head on the wall. Pt was sitting in chair, vitals attempted to be assessed, no reading, but patient alert. Before vitals were repeated,16:18 pt eyes drifted left and closing, another loss of consciousness, followed by convulsions and gasping sounds from the throat. Pt convulsed and left leg /foot turned inward torsion. Pt was removed from chair by 3 RN's to floor safely. approximately 15-30seconds of convulsion. pt regained consciousness AOX4. Pt remained laying, head propped on cushion. vitals taken 16:24 BP 108/69 86bpm, 100%O2Sat. MD assessed and pt stable. MD provided recommendation for pt to be evaluated at ED for further evaluation due to the convulsions. Pt accompanied by friend, friend agreed to drive pt to ED. Blood Glucose 90, which was taken at 1630.  Wheelchair was provided for patient, RN rolled pt out to car and friend designated driver.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Erythema
Clinical narrative: Oblong mark about 2 inches long with 3/4 inch blister in the middle to the left of bellybutton. Oblong mark about 2 inches long to the right of bellybutton. Redness went away within a couple of days. Blister is still healing as of 4-16-2021.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Headache, Nausea
Clinical narrative: I developed a headache across my forehead around 8:30pm that night 4/15/21 from 12:10pm vaccination.  I didn't take any medication.  I applied peppermint essential oil with no relief.  The headache was still present in the morning now with nausea from the headache.   I do not normally get headaches.  I took pamprin at 7:30am 4/16/21 and ate breakfast.  The headache has dissipated, however I feel it in the background and I am very cold.  My temperature is 98.2.  I am no longer nauseous.  My atlas was out of alignment so I was adjusted by a chiropractic clinic.  I will await to see if my headache returns or for other symptoms and take pamprin if necessary again.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Aphasia, Asthenia, Condition aggravated, Confusional state
Clinical narrative: Extreme weakness, can't stand up, low-grade fever, restlessness, dementia symptoms increased, confusion, anxiety, inability to find words or speak what's on his mind.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Dementia, Dysstasia, Pyrexia, Restlessness
Clinical narrative: Extreme weakness, can't stand up, low-grade fever, restlessness, dementia symptoms increased, confusion, anxiety, inability to find words or speak what's on his mind.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Administration error, the patient is 16 years old and Moderna is only indicated at this time for 18 years old and up. The patient experienced no ADRs
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Electrocardiogram normal, Full blood count normal, Headache, Influenza virus test negative
Clinical narrative: fever, rash, hives, palpitations, headache, syncope. Lasting 7 days after vaccination. Evaluated in the ED on 7th day post vaccine.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test, Palpitations, Pyrexia, Rash, SARS-CoV-2 test negative
Clinical narrative: fever, rash, hives, palpitations, headache, syncope. Lasting 7 days after vaccination. Evaluated in the ED on 7th day post vaccine.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope, Urticaria
Clinical narrative: fever, rash, hives, palpitations, headache, syncope. Lasting 7 days after vaccination. Evaluated in the ED on 7th day post vaccine.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Dizziness, Heart rate increased
Clinical narrative: Patient became dizzy, heart rate became elevated, and blood pressure became elevated. Patient did not improve after 15 minutes. EMS was activated and at scene in 10 minutes. Patient was walked out by EMS.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test, Anaphylactic shock, COVID-19, Full blood count, Headache
Clinical narrative: Started to have body aches, head aches and neck pain from next day morning and keep on progressing the symptoms even after 4 weeks. So tested for Covid on 2/23/21 and was positive. Also tested positive on 11/2/2020 and recovered in 3 weeks. My allergies increased in frequencies and intensity during last 12 weeks and had a severe anaphylactic shock 3 weeks ago which required calling 911 and ER treatment for stabilization. Till today, I have body aches, neck pain, insomnia and head aches and I am doing everything in my knowledge to improve my health. Multiple doctors and specialist appointments, are still continuing for treatment .
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammatory marker test, Insomnia, Metabolic function test, Neck pain, Pain
Clinical narrative: Started to have body aches, head aches and neck pain from next day morning and keep on progressing the symptoms even after 4 weeks. So tested for Covid on 2/23/21 and was positive. Also tested positive on 11/2/2020 and recovered in 3 weeks. My allergies increased in frequencies and intensity during last 12 weeks and had a severe anaphylactic shock 3 weeks ago which required calling 911 and ER treatment for stabilization. Till today, I have body aches, neck pain, insomnia and head aches and I am doing everything in my knowledge to improve my health. Multiple doctors and specialist appointments, are still continuing for treatment .
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Rheumatoid factor, SARS-CoV-2 test positive
Clinical narrative: Started to have body aches, head aches and neck pain from next day morning and keep on progressing the symptoms even after 4 weeks. So tested for Covid on 2/23/21 and was positive. Also tested positive on 11/2/2020 and recovered in 3 weeks. My allergies increased in frequencies and intensity during last 12 weeks and had a severe anaphylactic shock 3 weeks ago which required calling 911 and ER treatment for stabilization. Till today, I have body aches, neck pain, insomnia and head aches and I am doing everything in my knowledge to improve my health. Multiple doctors and specialist appointments, are still continuing for treatment .